Two more sites were used as controls: one within the prion gene (PRNP) and another within ANK1, a gene whose hypermethylation has consistently been reported in Alzheimer’s disease (AD) [33]. This evidence concerns the gene ANK1 and early-onset autosomal dominant Alzheimer disease.